ANDA 87614, held by Ivax Pharms. Trifluoperazine Hydrochloride.
As of Nov 15, 2026, ANDA 87614 (Trifluoperazine Hydrochloride), held by Ivax Pharms, was first approved by FDA on Nov 19, 1982, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Nov 19, 1982 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Trifluoperazine HydrochlorideEQ 10MG BASE ยท tablet;oral | Trifluoperazine Hydrochloride | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
